Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers-Reference-Cited by-同舟云学术

Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers

Published:2024-05 Issue:5 Volume:26 Page:413-422
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Rickles-Young Micah^ORCID,Tinoco Gabriel^ORCID,Tsuji Junko^ORCID,Pollock Sam,Haynam Marcy^ORCID,Lefebvre Heather,Glover Kristyn,Owen Dwight H.^ORCID,Collier Katharine A.,Ha Gavin,Adalsteinsson Viktor A.^ORCID,Cibulskis Carrie,Lennon Niall J.^ORCID,Stover Daniel G.^ORCID

Funder

National Cancer Institute

Gerstner Family Foundation

Publisher

Elsevier BV

Reference30 articles.

1. Circulating tumor DNA markers for early progression on fulvestrant with or without palbociclib in ER+ advanced breast cancer;O’Leary;J Natl Cancer Inst,2020

2. Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancer;Stover;J Clin Oncol,2018

3. Tumor fraction in cell-free DNA as a biomarker in prostate cancer;Choudhury;JCI Insight,2018

4. Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study;Reichert;Ann Oncol,2023

5. Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment;Dandachi;Mol Oncol,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma;Cancers;2024-09-01

2. Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC;Scientific Reports;2024-08-09

3. Impact of preanalytical factors on liquid biopsy in the canine cancer model;2024-07-30